BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30525593)

  • 1. Modeling of Halogen-Protein Interactions in Co-Solvent Molecular Dynamics Simulations.
    Yang Y; Mahmoud AH; Lill MA
    J Chem Inf Model; 2019 Jan; 59(1):38-42. PubMed ID: 30525593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance assessment of semiempirical molecular orbital methods in describing halogen bonding: quantum mechanical and quantum mechanical/molecular mechanical-molecular dynamics study.
    Ibrahim MA
    J Chem Inf Model; 2011 Oct; 51(10):2549-59. PubMed ID: 21942911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition.
    Celis-Barros C; Saavedra-Rivas L; Salgado JC; Cassels BK; Zapata-Torres G
    J Comput Aided Mol Des; 2015 Jan; 29(1):37-46. PubMed ID: 25338130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polarizable ellipsoidal force field for halogen bonds.
    Du L; Gao J; Bi F; Wang L; Liu C
    J Comput Chem; 2013 Sep; 34(23):2032-40. PubMed ID: 23804187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments.
    Hardegger LA; Kuhn B; Spinnler B; Anselm L; Ecabert R; Stihle M; Gsell B; Thoma R; Diez J; Benz J; Plancher JM; Hartmann G; Isshiki Y; Morikami K; Shimma N; Haap W; Banner DW; Diederich F
    ChemMedChem; 2011 Nov; 6(11):2048-54. PubMed ID: 21898833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametrization of halogen bonds in the CHARMM general force field: Improved treatment of ligand-protein interactions.
    Soteras Gutiérrez I; Lin FY; Vanommeslaeghe K; Lemkul JA; Armacost KA; Brooks CL; MacKerell AD
    Bioorg Med Chem; 2016 Oct; 24(20):4812-4825. PubMed ID: 27353885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular design and validation of halogen bonding orthogonal to hydrogen bonding in breast cancer MDM2-peptide complex.
    Huang A; Zhou L; Zhang D; Yao J; Zhang Y
    J Mol Graph Model; 2016 Nov; 70():40-44. PubMed ID: 27649550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery.
    Zimmermann MO; Lange A; Wilcken R; Cieslik MB; Exner TE; Joerger AC; Koch P; Boeckler FM
    Future Med Chem; 2014 Apr; 6(6):617-39. PubMed ID: 24895892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halogen Bonding in Haspin-Halogenated Tubercidin Complexes: Molecular Dynamics and Quantum Chemical Calculations.
    Zhou Y; Wong MW
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantum mechanics-based halogen bonding scoring function for protein-ligand interactions.
    Yang Z; Liu Y; Chen Z; Xu Z; Shi J; Chen K; Zhu W
    J Mol Model; 2015 Jun; 21(6):138. PubMed ID: 25957658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Dynamics in Mixed Solvents Reveals Protein-Ligand Interactions, Improves Docking, and Allows Accurate Binding Free Energy Predictions.
    Arcon JP; Defelipe LA; Modenutti CP; López ED; Alvarez-Garcia D; Barril X; Turjanski AG; Martí MA
    J Chem Inf Model; 2017 Apr; 57(4):846-863. PubMed ID: 28318252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics of halogen bonding in solution: substituent, structural, and solvent effects.
    Sarwar MG; Dragisic B; Salsberg LJ; Gouliaras C; Taylor MS
    J Am Chem Soc; 2010 Feb; 132(5):1646-53. PubMed ID: 20078063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unstable, metastable, or stable halogen bonding interaction involving negatively charged donors? A statistical and computational chemistry study.
    Yang Z; Xu Z; Liu Y; Wang J; Shi J; Chen K; Zhu W
    J Phys Chem B; 2014 Dec; 118(49):14223-33. PubMed ID: 25390886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halogen bonding in ligand-receptor systems in the framework of classical force fields.
    Rendine S; Pieraccini S; Forni A; Sironi M
    Phys Chem Chem Phys; 2011 Nov; 13(43):19508-16. PubMed ID: 21964576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameter choice matters: validating probe parameters for use in mixed-solvent simulations.
    Lexa KW; Goh GB; Carlson HA
    J Chem Inf Model; 2014 Aug; 54(8):2190-9. PubMed ID: 25058662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexahalogenated and their mixed benzene derivatives as prototypes for the understanding of halogen···halogen intramolecular interactions: New insights from combined DFT, QTAIM-, and RDG-based NCI analyses.
    Varadwaj PR; Varadwaj A; Jin BY
    J Comput Chem; 2015 Dec; 36(31):2328-43. PubMed ID: 26505258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Application of Ligand-Mapping Molecular Dynamics Simulations to the Rational Design of Peptidic Modulators of Protein-Protein Interactions.
    Tan YS; Spring DR; Abell C; Verma CS
    J Chem Theory Comput; 2015 Jul; 11(7):3199-210. PubMed ID: 26575757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket.
    Pradhan MR; Siau JW; Kannan S; Nguyen MN; Ouaray Z; Kwoh CK; Lane DP; Ghadessy F; Verma CS
    Nucleic Acids Res; 2019 Feb; 47(4):1637-1652. PubMed ID: 30649466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does halogen bonding behave in solution? A theoretical study using implicit solvation model.
    Lu Y; Li H; Zhu X; Zhu W; Liu H
    J Phys Chem A; 2011 May; 115(17):4467-75. PubMed ID: 21466189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomolecular halogen bonds.
    Ho PS
    Top Curr Chem; 2015; 358():241-76. PubMed ID: 25326832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.